Cargando…

Diffuse erythematous rash after teneligliptin therapy: A case report

We report a yet unreported, adverse effect of teneligliptin [Dipeptidyl peptidase IV inhibitor (DPP IV)] presenting as diffuse pruritic erythematous rash, in a patient, 2 days after initiation of the drug. The rash waned off after the discontinuation of the drug without any residual lesion.

Detalles Bibliográficos
Autores principales: Agrawal, Prabhat, Jain, Apoorv, Bansal, Saurabh, Raj, Abhishek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293926/
https://www.ncbi.nlm.nih.gov/pubmed/30613561
http://dx.doi.org/10.4103/jfmpc.jfmpc_283_18

Ejemplares similares